このアイテムのアクセス数: 18
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
s13321-025-00967-9.pdf | 2.04 MB | Adobe PDF | 見る/開く |
タイトル: | kMoL: an open-source machine and federated learning library for drug discovery |
著者: | Cozac, Romeo Hasic, Haris Choong, Jun Jin Richard, Vincent Beheshti, Loic Froehlich, Cyrille Koyama, Takuto Matsumoto, Shigeyuki ![]() ![]() ![]() Kojima, Ryosuke ![]() ![]() ![]() Iwata, Hiroaki Hasegawa, Aki Otsuka, Takao Okuno, Yasushi |
キーワード: | Machine learning Federated learning Drug discovery Deep learning Graph convolutional networks Distributed learning Chemoinformatics |
発行日: | 25-Feb-2025 |
出版者: | Springer Nature |
誌名: | Journal of Cheminformatics |
巻: | 17 |
号: | 1 |
論文番号: | 22 |
抄録: | Machine learning is quickly becoming integral to drug discovery pipelines, particularly quantitative structure-activity relationship (QSAR) and absorption, distribution, metabolism, and excretion (ADME) tasks. Graph Convolutional Network (GCN) models have proven especially promising due to their inherent ability to model molecular structures using graph-based representations. However, maximizing the potential of such models in practice is challenging, as companies prioritize data privacy and security over collaboration initiatives to improve model performance and robustness. kMoL is an open-source machine learning library with integrated federated learning capabilities developed to address such challenges. Its key features include state-of-the-art model architectures, Bayesian optimization, explainability, and federated learning mechanisms. It demonstrates extensive customization possibilities, advanced security features, straightforward implementation of user-specific models, and high adaptability to custom datasets without additional programming requirements. kMoL is evaluated through locally trained benchmark settings and distributed federated learning experiments using various datasets to assess the features and flexibility of the library, as well as the ability to facilitate fast and practical experimentation. Additionally, results of these experiments provide further insights into the performance trade-offs associated with federated learning strategies, presenting valuable guidance for deploying machine learning models in a privacy-preserving manner within drug discovery pipelines. |
URI: | http://hdl.handle.net/2433/292637 |
DOI(出版社版): | 10.1186/s13321-025-00967-9 |
PubMed ID: | 40001146 |
出現コレクション: | 学術雑誌掲載論文等 |

このリポジトリに保管されているアイテムはすべて著作権により保護されています。